Weight loss injections do not directly affect menstrual cycles
The key difference between semaglutide and tirzepatide regarding thyroid interaction is potency
14.5 MOUNJARO Use in Combination with Metformin or Basal Insulin, or Both in Pediatric Patients 10 Years of Age and Older with Type 2 Diabetes Mellitus SURPASS-PEDS (NCT05260021) was a 30-week double-blind, placebo-controlled trial with a 22-week open-label extension that randomized 99 pediatric patients 10 years of age and older with type 2 diabetes mellitus with inadequate glycemic control on metformin (69%), or basal insulin (8%), or both (23%) to receive subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, or placebo once weekly as add-on therapy
If you do have insurance, the price will greatly depend on your plan details, including out-of-pocket responsibility
Take a look at our articles on the FDA-approved treatments for this condition, topical minoxidil and oral finasteride
How long someone stays on it varies and depends on metabolic health, weight history, and how well results are maintained over time